Viracept (State of Florida DOH Central Pharmacy)
Welcome to the PulseAid listing for the Viracept drug offered from State of Florida DOH Central Pharmacy. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | State of Florida DOH Central Pharmacy |
NON-PROPRIETARY NAME: | NELFINAVIR MESYLATE |
SUBSTANCE NAME: | NELFINAVIR MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
Viracept HUMAN PRESCRIPTION DRUG Details:
Item Description | Viracept from State of Florida DOH Central Pharmacy |
LABELER NAME: | State of Florida DOH Central Pharmacy |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 625(mg/1) |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53808-0809_d93799ad-308b-4f54-b8d5-07402cd8882e |
PRODUCT NDC: | 53808-0809 |
APPLICATION NUMBER: | NDA021503 |
Other NELFINAVIR MESYLATE Pharmaceutical Manufacturers / Labelers: